Welcome, Guest |
TOPIC:
HCV New Drugs Blogspot 7 years 10 months ago #17631
This is hell on a phone... Drug Rationing Plays Russian Roulette With Patients’ Lives hepatitiscnewdrugs.blogspot.com/2016/06/...an-roulette.html?m=1 2,436 patients with hepatitis C in one Alabama ER since implementing widespread testing in 2013 hepatitiscnewdrugs.blogspot.com/2016/06/...is-c-in-one.html?m=1 Survival rates rise with new hepatitis C treatments hepatitiscnewdrugs.blogspot.com/2016/06/...w-hepatitis.html?m=1 ****4 Week Tx***** Regulus Reports Positive Data/Phase II studies of RG-101 for the treatment of Hepatitis C hepatitiscnewdrugs.blogspot.com/2016/06/...ataphase-ii.html?m=1 Foretelling toxicity: FDA researchers work to predict risk of liver injury from drugs hepatitiscnewdrugs.blogspot.com/2016/05/...researchers.html?m=1 FDA warns against fake Hepatitis C medicines hepatitiscnewdrugs.blogspot.com/2016/05/...hepatitis-c.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 10 months ago #17800
Outcomes in patients with chronic Hep C treated with different anti-viral regimens hepatitiscnewdrugs.blogspot.com/2016/06/...ronic-hep-c.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 10 months ago #17943
Making Hepatitis C A Rare Disease In The United States hepatitiscnewdrugs.blogspot.ro/2016/06/m...-disease-in.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 10 months ago #18444
A new non-DAA about to commence Phase 1 trials. Looks like it may have potential for 'difficult to treat' cases if proven. hepatitiscnewdrugs.blogspot.com.au/2016/...f-concept-study.html G3a since '78 - Dx '12 - F4 (2xHCC) 24wk Tx - PEG/Riba/Dac 2013 relapsed 24wk Tx - Generic Sof/Dac/Riba 2015/16 relapsed 16wk Tx - 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof SVR7 - 22/06/17 UND SRV12 - 27/07/17 UND SVR24 - 26/10/17 UND | |
HCV New Drugs Blogspot 7 years 10 months ago #18446
"Interferon- and ribavirin-containing regimens negatively impact patients’ experience. " They can pop that in BOLD! Gen 1a Peg/inf/riba 2012(!) stop @ Wk 43 potassium low +issues (rlps week 4 post tx, VL120,000) scnds eg. adenomas. pre sof/led VL 240,000 Fibsc F0 Day 25 <30 Day 32 UND Week 10 UND EOT UND ALT11AST17GGT19 SVR4 UND ALT10 AST16 GGT13 SVR8 UND ALT <9 AST16 GGT15 SVR12 UND ALT14 AST19 GGT12 Bili 5 EOT +18 ALT13 AST20 GGT9 Bili 5 EOT +21 ALT11AST15 Cured SVR12 Dysplasia Adenomas RemvdAug '16 SVR24 UND ALT11AST16 ColonoscopyClear Nov17 LumpectomyClear ‘18 LithotripsyCytoscopyBiopsy 4/18 | |
HCV New Drugs Blogspot 7 years 10 months ago #18586
Now that we have the hepatitis C virus on the run, can a universal cure be attained? hepatitiscnewdrugs.blogspot.com/2016/06/...-c-virus-on.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 10 months ago #18587
Thanks Mike. they had a good list of references, but were missing an important one. I added a highlight from latest Liver International journal. Genotype 3 30 years, 2x treatment interferon/ribavirin non responder. Cirrhosis 17 years. Fibroscan, decompensating, 40 down to 22 by 29/3/16- now down to 6.5, normal, no cirrhosis. Started Buyers Club Sof/Dac 14 Nov 15. SVR 12 29/0716 | |
HCV New Drugs Blogspot 7 years 10 months ago #18588
Ty Mike, many interesting studies to read plus some good coffee news p5 Setiawan and colleagues[16] evaluated the protective effect of coffee drinking in black, Native Hawaiian, Japanese American, Latino, and white patients with chronic liver diseases. Regular coffee intake was associated with reduced risks for NAFLD-related progression in a dose-dependent manner. For example, compared with non–coffee drinkers, those who reported drinking two to three cups and four or more cups of coffee per day had a 14% and a 34% reduction, respectively, in the risk for NAFLD-related disease. High consumption (four or more cups per day of regular coffee) was associated with a reduced risk for HCV-related chronic liver disease. gt 1a VL 6m F2/3 FibroScan - 9KPa in 2011 and 7KPa in 2015 sof/dac 10 December for 12 weeks pre tx alt 85 ast 51 4 wk alt 34 ast 31 UND <35 8 wk alt 29 ast 32 UND <15 12wk alt 25 ast 25 EOT 3.3.16 SVR24 UND KPa5.3 F0 in normal range I am well .forever grateful to fixhepc | |
HCV New Drugs Blogspot 7 years 9 months ago #19266
HCV Guidelines Update: Reflect Recent Approval of Epclusa (Sofosbuvir/Velpatasvir) hepatitiscnewdrugs.blogspot.com/2016/07/...lect-recent.html?m=1 Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially For Genotypes 2 and 3 hepatitiscnewdrugs.blogspot.com/2016/07/...r-makes-hcv.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 9 months ago #19310
Gilead's Epclusa® - European Commission Grants Marketing Authorization hepatitiscnewdrugs.blogspot.com/2016/07/...-commission.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 The following user(s) said Thank You: fitz | |
HCV New Drugs Blogspot 7 years 9 months ago #19404
Epclusa among hepatitis drugs that are medical miracles of the 21st century hepatitiscnewdrugs.blogspot.com/2016/07/...gs-that-are.html?m=1 Hazel Heal!!! hepatitiscnewdrugs.blogspot.com/2016/07/...ers-club_11.html?m=1 Watch - New Opportunities and Challenges in Hepatitis C hepatitiscnewdrugs.blogspot.com/2016/07/...-challenges.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 9 months ago #19451
Generic Medications for Hepatitis C hepatitiscnewdrugs.blogspot.com/2016/07/...hepatitis-c.html?m=1 Hmmmmm... This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 9 months ago #19587
Treatment of Chronic Hepatitis C in the Aged – Does It Impact Life Expectancy? A Decision Analysis hepatitiscnewdrugs.blogspot.com/2016/07/...atitis-c-in.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 9 months ago #20102
David Bernstein: Managing Risk Factors in Hepatitis C hepatitiscnewdrugs.blogspot.com/2016/07/...d-hepatitis.html?m=1 UK health service under fire over access to hepatitis C drugs hepatitiscnewdrugs.blogspot.com/2016/07/...r-fire-over.html?m=1 New medication shows promise against liver fibrosis in animal studies hepatitiscnewdrugs.blogspot.com/2016/07/...ise-against.html?m=1 hepatitiscnewdrugs.blogspot.com/2016/07/...aa-regimens.html?m=1 Discovery of new Hepatitis C Virus mechanism hepatitiscnewdrugs.blogspot.com/2016/07/...tis-c-virus.html?m=1 This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
HCV New Drugs Blogspot 7 years 8 months ago #20547
Elbasvir-grazoprevir works effectively against HCV despite current drug use hepatitiscnewdrugs.blogspot.com/2016/08/...rks-effectively.html 'Tax haven' Ireland accused of helping US firm treble untaxed profits hepatitiscnewdrugs.blogspot.com/2016/08/...d-of-helping-us.html Why are hepatitis C patients treated differently by NHS England? hepatitiscnewdrugs.blogspot.com/2016/08/...atients-treated.html This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 | |
Time to create page: 0.092 seconds